How have RLMD and SMTI total returns compared?

Over the past 10 years, RLMD delivered 12.41% and SMTI delivered 24.23% annualized total return. Past performance doesn't predict future results.

Relmada Therapeutics, Inc. (RLMD) vs Sanara MedTech Inc. (SMTI)

A side-by-side comparison of Relmada Therapeutics, Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

RLMD

Relmada Therapeutics, Inc.

$344M

$3.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SMTI

Sanara MedTech Inc.

$322M

$35.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — RLMD vs SMTI

growth of $100 · dividends reinvested · last 10y

RLMD +231.4% (+12.7%/yr)SMTI +775.0% (+24.2%/yr)SMTI compounded faster over this window

RLMD SMTI

RLMD vs SMTI: by the numbers

•RLMD is the larger company ($344M vs $322M market cap).
•Both run net losses; RLMD's is the smaller (0.00% vs -29.15% net margin).

Metrics side by side

Valuation

Metric	RLMD	SMTI
Forward P/E	N/A	184.21
P/S ratio	N/A	2.93
P/B ratio	1.67	40.51
EV / EBITDA	N/A	27.80
FCF yield	N/A	1.40%

Profitability

Metric	RLMD	SMTI
Gross margin	0.00%	91.33%
Operating margin	0.00%	9.36%
Net margin	0.00%	-29.15%
ROE	-29.98%	-403.03%
ROIC	-30.78%	18.15%

Growth (annualized)

Metric	RLMD	SMTI
Revenue CAGR (5Y)	N/A	40.06%
Total return CAGR (5Y)	-7.68%	0.35%

Frequently asked

How have RLMD and SMTI total returns compared?: Over the past 10 years, RLMD delivered 12.41% and SMTI delivered 24.23% annualized total return. Past performance doesn't predict future results.

Go deeper

Full RLMD analysis Full SMTI analysis Interactive comparison tool

Dig into the metrics

Relmada Therapeutics ROE Sanara MedTech ROE Relmada Therapeutics operating margin Sanara MedTech operating margin Relmada Therapeutics revenue growth Sanara MedTech revenue growth Relmada Therapeutics free cash flow Sanara MedTech free cash flow

Relmada Therapeutics & Sanara MedTech appear in these rankings

Fastest Revenue Growth Stocks Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.